1.Budka, H. Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991;1:163–75.
2.Navia, BA, Cho, ES, Petito, CK, Price, RW. The AIDS dementia complex: II. Neuropathology. Annals Neurol 1986;19:525–35.
3.Das, G, Baglioni, P, Okosieme, O. Primary HIV infection. BMJ 2010;341:c4583.
4.Palfreeman, A, Fisher, M, Ong, E, et al. Testing for HIV: concise guidance. Clin Med 2009;9:471–6.
5.Sonnerborg, AB, Ehrnst, AC, Bergdahl, SK, et al. HIV isolation from cerebrospinal fluid in relation to immunological deficiency and neurological symptoms. AIDS 1988;2:89–93.
6.Cysique, LA, Vaida, F, Letendre, S, et al. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 2009;73:342–8.
7.Williams, I, Churchill, D, Anderson, J, et al. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Med 2012;13:1–85.
8.Letendre, S, Marquie-Beck, J, Capparelli, E, et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008;65:65–70.
9.Heaton, RK, Clifford, DB, Franklin, DR Jr, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010;75:2087–96.
10.Health Protection Agency. HIV in the United Kingdom: 2011 Report. London: Health Protection Services; 2011.
11.Nightingale, S, Michael, BD, Defres, S, Benjamin, LA, Solomon, T. Test them all; an easily diagnosed and readily treatable cause of dementia with life-threatening consequences if missed. Pract Neurol 2013;13:354–6.